225 related articles for article (PubMed ID: 16901397)
1. Clinical and molecular prognostic factors in follicular lymphoma.
Davies AJ
Curr Oncol Rep; 2006 Sep; 8(5):359-67. PubMed ID: 16901397
[TBL] [Abstract][Full Text] [Related]
2. How I treat early-relapsing follicular lymphoma.
Casulo C; Barr PM
Blood; 2019 Apr; 133(14):1540-1547. PubMed ID: 30700421
[TBL] [Abstract][Full Text] [Related]
3. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
Boughan KM; Caimi PF
Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
[TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma grade 3: review and updates.
Vaidyanathan G; Czuczman MS
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in follicular lymphoma.
Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model.
Andjelić B; Todorović-Balint M; Antić D; Bila J; Djurašinović V; Mihaljević B
Vojnosanit Pregl; 2015 Jan; 72(1):26-32. PubMed ID: 26043587
[TBL] [Abstract][Full Text] [Related]
7. Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy.
Yamamoto M; Tanaka K; Umezawa Y; Nagao T; Toyota S; Miura O
Anticancer Res; 2019 Sep; 39(9):5115-5122. PubMed ID: 31519623
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
[TBL] [Abstract][Full Text] [Related]
9. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
10. Refining the treatment of follicular lymphoma.
Buske C; Gisselbrecht C; Gribben J; Letai T; McLaughlin P; Wilson W
Leuk Lymphoma; 2008; 49 Suppl 1():18-26. PubMed ID: 18821429
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in follicular lymphoma: new tools to personalize risk.
Casulo C
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):269-276. PubMed ID: 27913491
[TBL] [Abstract][Full Text] [Related]
12. Prognostic tools in follicular lymphomas.
Luminari S; Cox MC; Montanini A; Federico M
Expert Rev Hematol; 2009 Oct; 2(5):549-62. PubMed ID: 21083020
[TBL] [Abstract][Full Text] [Related]
13. Pediatric-type Follicular Lymphoma and Pediatric Nodal Marginal Zone Lymphoma: Recent Clinical, Morphologic, Immunophenotypic, and Genetic Insights.
Koo M; Ohgami RS
Adv Anat Pathol; 2017 May; 24(3):128-135. PubMed ID: 28277421
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification in follicular lymphoma.
Casulo C
Best Pract Res Clin Haematol; 2018 Mar; 31(1):15-22. PubMed ID: 29452661
[TBL] [Abstract][Full Text] [Related]
15. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
Patel AA; Smith SM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of prognostic indices in patients with follicular lymphomas.
Radojkovic M; Ristic S; Colovic M; Mihaljevic B; Cemerikic-Martinovic V
Med Oncol; 2006; 23(4):533-42. PubMed ID: 17303912
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
19. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]